After the treatment with IL-13, cancer cells knocked down for PTP1B, showed an increase of IL13Rα2 on the cell surface (Supplementary Figure S1A) together with less protein degradation (Supplementary Figure S1B). This evidence concerns the gene IL13RA2 and cancer.